Gateway System is Portal's research-scale mechanical delivery instrument for intracellular cargo.

Portal Biotechnologies
Portal Biotechnologies provides a mechanical cell-engineering platform for biopharma and academic research.
- Company
- Arlington, MA, USUnited States
Portal Biotechnologies develops a universal cell engineering platform built on proprietary mechanical membrane-disruption technology. Its system enables high-throughput, scalable intracellular delivery of RNA, gene editors, probes, and other cargos into diverse hard-to-transfect cell types for research and therapeutic applications.
The company supports drug discovery workflows, AI data generation, and cell therapy partnerships, and has reported more than 100 customers across top pharmaceutical and academic centers. It was established in 2023 and is led by founder and CEO Armon Sharei, Ph.D.
Products & Services
Similar Companies

Thermo Fisher Scientific
thermofisher.com

Bio-Rad
bio-rad.com

Navan Technologies
navanbio.com

Mana.bio
mana.bio

Mercury Bio
mercurybio.com

Sigma Genetics
sigmagenetics.com

Prolific Machines

CellFE
cellfebiotech.com

eGenesis
egenesisbio.com

Optimeos Life Sciences
optimeos.com

Portal Instruments
Solstice Biologics

Mekonos
mekonos.com

Enoda
enoda.bio

Interius BioTherapeutics
interiusbio.com

Kytopen
kytopen.com

Korro Bio
korrobio.com
Sivec Biotechnologies

Vesigen Therapeutics
vesigen.com

Inceptive
inceptive.life
Quick Facts
Who are Portal Biotechnologies' competitors?
Companies similar to Portal Biotechnologies include Thermo Fisher Scientific, Bio-Rad, Navan Technologies and Mana.bio.
When was Portal Biotechnologies founded?
Portal Biotechnologies was founded in 2023.
Where is Portal Biotechnologies' headquarters located?
Portal Biotechnologies' headquarters is located in Arlington, MA, US.
When was Portal Biotechnologies' last funding round?
Portal Biotechnologies' most recent funding round was for $9M (USD) in June 2026.
How much disclosed funding has Portal Biotechnologies raised?
As of Jun 18, 2026, Portal Biotechnologies has disclosed funding of $21M (USD). Undisclosed round amounts are excluded.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Model
- Revenue
- Customer
- Also Known As
- Portal Biotechnologies, Inc.
- Headquarters
- 27 Brunswick Rd.
- Arlington, MA, 02476
- US
- SEC CIK
- 0002049466